Juno Bio is a biotechnology startup based in the United Kingdom, founded in 2018. The company is on a mission to decode the vaginal microbiome to close the gender health gap. Their efforts have garnered support from Illumina, a renowned name in the industry. The latest investment, a Convertible Note investment, took place on 18 August 2020 and was led by Acequia Capital. With its innovative approach and backing from industry leaders, Juno Bio is poised to make a significant impact in the field of women's health and biotechnology.
Juno Bio
Juno Bio is the world's first and fastest vaginal microbiome testing company.
Founded 2018
London, United States
6 employees
Seed
Total: $3.80M
Biotechnology, Life Sciences +2
London, United States
6 employees
Seed
Total: $3.80M
Biotechnology, Life Sciences +2
General Information
Company Name
Juno Bio
Founded Year
2018
Location
London, United States
London, United States
Employees
6
Industries
Biotechnology, Life Sciences, Clean Energy +1
Funding Stage
Seed
BounceWatch is an independent company data service, not affiliated with Juno Bio. To contact Juno Bio, visit juno.bio.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Juno Bio compare?
A PDF of Juno Bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Juno Bio soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
United States Market
Biotechnology
About Juno Bio
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Seed | $3.80M | 4 |
|
16 Jul 2026 |
| Convertible Note | Undisclosed | 1 |
Acequia Capital (AceCap)
|
18 Aug 2020 |
| Seed Round | Undisclosed | 2 |
|
01 Jan 2020 |
Latest News
View All
Juno Bio Alternatives & Competitors
View All Alternatives
Juno Bio vs
Intus Bio
United States
Revolutionary microbiome research, discovery & testing
Venture round
15 employees
Biotechnology, Health Care
Juno Bio vs
Mastering the microbiome, transforming lives®
Venture round
55 employees
Biotechnology, Health Care
Juno Bio vs
BrilliantBiome
United States
The microbiome precision medicine platform for the gut-brain axis.
Seed
4 employees
Analytics, Big Data
FAQ About Juno Bio
Juno Bio is the world's first and fastest vaginal microbiome testing company.
Juno Bio was founded in 2018.
Juno Bio is headquartered in London, United States.
Juno Bio operates in Biotechnology, Life Sciences, Clean Energy and Machine Learning.
Juno Bio has approximately 6 employees.
Juno Bio has completed 3 funding rounds, raising a total of $3.80M. The latest funding stage is Seed.
Top alternatives and competitors to Juno Bio include Intus Bio, EnteroBiotix, BrilliantBiome, YouCount Inc., IOME BIO. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Juno Bio and Intus Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for Juno Bio, https://bouncewatch.com/company/juno-bio, updated 16 July 2026. When citing, please name BounceWatch and link this page.
